-
HNP-1 Reverses Hypertensive Left Ventricular Hypertrophy by Inhibiting the NF-кB Signaling Pathway
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Human neutrophil peptide-1 (HNP-1) is a commonly investigated therapeutic agent. However, its role in hypertensive left ventricular hypertrophy (HLVH)…
-
Embedding R inside the PhysPK Bio-simulation Software for Pharmacokinetics Population Analysis
Announcing a new article publication for BIO Integration journal. PhysPK stands as a flexible and robust bio-simulation and modeling software designed for analysis of population pharmacokinetics (PK) and pharmacodynamics (PD)…
-
BIO Integration, Volume 4, Issue Number 2, Publishes
Guangzhou, September 7, 2023: BIO Integration (BIOI) publishes volume 4, issue 2. BIOI is a peer-reviewed, open access, international journal, which is dedicated to spreading multidisciplinary views driving the advancement…
-
First experiments with carbon black pigment dispersion acting as a Janus ultrasound contrast agent
Announcing a new article publication for BIO Integration journal. Theranostic ultrasound contrast agents comprise a therapeutic component whose controlled release is triggered by an ultrasound pulse. However, once the therapeutic…
-
Peptide Assemblies as Promising Tumor Vaccines: Current Platforms and Progress
Announcing a new article publication for BIO Integration journal. Self-assembled peptide-based vaccines, consisting of epitope-bearing peptides, can form diverse nanostructural morphologies, which could be endocytosed and presented by DCs to…
-
Bio Integration Achieves new Milestone
We are delighted to announce that with the official release of the 2022 citation metrics in Scopus, the most comprehensive bibliographic database of scientific literature, Bio Integration (BIOI) has a…
-
Call for Papers Bio Integration
Platinum open access journal- no APCs during 2023 Fast publication times You are invited to submit an article to BIO Integration (BIOI). BIO Integration (BIOI) seeks to publish multidisciplinary views driving…
-
HER2-targeting Peptide Drug Conjugate with Better Penetrability for Effective Breast Cancer Therapy
Announcing a new article publication for BIO Integration journal. Antibody-drug conjugates (ADCs) have the following advantages: target specificity; wide therapeutic index; and prolonged circulation half-life. A key limitation of ADCs,…